Home / News / Data Analysis #datamonitor #healthcare, #drg, #decision #resources #group, #global #data, #pharmaceutical #unmet #needs, #drug #pricing #and #reimbursement

Data Analysis #datamonitor #healthcare, #drg, #decision #resources #group, #global #data, #pharmaceutical #unmet #needs, #drug


#

Datamonitor Healthcare

Timely, in-depth, research and expert analysis of the pharmaceutical and biotechnology industries

Datamonitor Healthcare’s expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions. Its accurate and objective drug sales forecasts and segmented patient based disease forecasts are continually updated in reaction to key changes in the market, ensuring decisions are always based on the current reality of the market place.

  • Prioritize market opportunities
  • Identify unmet needs
  • Make informed decisions

Event sensitive

“Give me a real-time view of the pharma trends so that I’m always the first to know”

As the pharma industry evolves, it’s important to know you are basing your decisions on analysis that reflects the very latest trends and issues. With event-sensitive analysis, you can build your strategy based on analysis and forecasts that are reliable and accurate, to give you the tools to rapidly respond to changes across key diseases areas, companies and drugs.

  • Evaluate your drug’s clinical and commercial potential against related treatments based on emerging clinical trial results and treatment guidelines

About Author: